Cyclo(prolylglycyl)

Cyclic Dipeptide (diketopiperazine)Rx: UnknownCompound: Research

Also known as: 2,5-diketopiperazine, 2,5-diketopiperazine-Pro-Gly, CPG, cyclo(L-prolyl-glycyl), cyclo(Pro-Gly), cyclo(Pro‑Gly), Pro-Gly DKP

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Cyclo(prolylglycyl) at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Cyclo(prolylglycyl) (cyclo(Pro‑Gly)) is a simple cyclic dipeptide formed from proline and glycine, commonly encountered as a natural product and used as a scaffold in peptide chemistry.

Mechanism of Action

Cyclo(Pro-Gly) is a diketopiperazine formed by cyclization of proline and glycine. It has been reported to modulate GABA-A receptors and interact with benzodiazepine binding sites, potentially exhibiting anxiolytic and neuroprotective properties. It may also influence dopaminergic and serotonergic neurotransmission at the CNS level.

Routes of Administration

IntraperitonealIntravenousOral

Goals & Uses

  • NeuroprotectionNeurologyLow
  • Anxiolytic effectNeuropsychiatricLow
  • Nootropic / cognitive enhancementCognitiveLow
  • AnticonvulsantNeurologicalLow

Contraindications

  • Known hypersensitivity to proline or glycine derivativesAllergyHigh

Adverse Effects

  • Unknown systemic effectsGeneralUnknown

Drug Interactions

  • BenzodiazepinesLow
  • GABAergic agentsLow

Population Constraints

  • Pregnant or lactating individualsReproductiveRelative
  • Pediatric populationsAgeRelative
  • ElderlyAgeRelative

Regulatory Status

  • European UnionUnapprovedNot EMA-approved; no IMPD or clinical trial registration identified.
  • United StatesUnapprovedNot FDA-approved; no IND or clinical trial registration identified.
  • United KingdomUnapprovedNot MHRA-approved; research compound only.

Not approved by any major regulatory agency (FDA, EMA, MHRA) for any therapeutic indication. Investigated exclusively in preclinical research settings.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is Cyclo(prolylglycyl)?

Cyclo(prolylglycyl) (cyclo(Pro‑Gly)) is a simple cyclic dipeptide formed from proline and glycine, commonly encountered as a natural product and used as a scaffold in peptide chemistry.

What is Cyclo(prolylglycyl) used for?

Cyclo(prolylglycyl) is educationally associated with: Neuroprotection, Anxiolytic effect, Nootropic / cognitive enhancement, Anticonvulsant. Educational only — not medical advice.

How is Cyclo(prolylglycyl) administered?

Recorded routes of administration: Intraperitoneal, Intravenous, Oral.

What are the potential side effects of Cyclo(prolylglycyl)?

Reported adverse effects include: Unknown systemic effects. This list is not exhaustive — consult a qualified clinician.

Who should avoid Cyclo(prolylglycyl)?

Recorded contraindications: Known hypersensitivity to proline or glycine derivatives. Consult a qualified clinician before use.

More in this class